[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100422833":3},{"organization":4,"outcomesModule":7,"designInfo":49,"detailedDescription":48,"studyPopulation":52,"armGroups":53,"interventions":61,"overallOfficials":67,"centralContacts":93,"locations":102,"responsibleParty":132,"collaborators":135,"id":138,"slug":139,"hasResults":140,"nctId":141,"briefTitle":142,"officialTitle":143,"acronym":144,"eligibilityCriteria":145,"healthyVolunteers":140,"sex":146,"minAge":48,"maxAge":48,"enrollmentInfo":147,"targetDuration":48,"studyType":150,"phases":48,"briefSummary":151,"conditions":152,"keywords":48,"overallStatus":104,"whyStopped":48,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":162,"locationsCount":163},{"fullName":5,"class":6},"Beijing Tiantan Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":25,"otherOutcomes":48},[9,13,16,19,22],{"measure":10,"description":11,"timeFrame":12},"Unfavorable neurological outcome (mRS>2)","Number of patients experiencing a unfavorable neurological outcome at discharge, defined as a modified Rankin Scale (mRS) score of \\>2.","10 days after the procedure",{"measure":10,"description":14,"timeFrame":15},"Number of patients experiencing a unfavorable neurological outcome at 3 months post-treatment, defined as a modified Rankin Scale (mRS) score of \\>2.","3 months",{"measure":10,"description":17,"timeFrame":18},"Number of patients experiencing a unfavorable neurological outcome at 6 months post-treatment, defined as a modified Rankin Scale (mRS) score of \\>2.","6 months",{"measure":10,"description":20,"timeFrame":21},"Number of patients experiencing a unfavorable neurological outcome at 12 months post-treatment, defined as a modified Rankin Scale (mRS) score of \\>2.","12 months",{"measure":10,"description":23,"timeFrame":24},"Number of patients experiencing a unfavorable neurological outcome at 24 months post-treatment, defined as a modified Rankin Scale (mRS) score of \\>2.","24 months",[26,29,31,33,35,37,40,42,44,46],{"measure":27,"description":28,"timeFrame":12},"Cognitive deficits","Number of patients experiencing a unfavorable neurological outcome at discharge,defined as changes in thinking, emotion, will and behavior.",{"measure":27,"description":30,"timeFrame":15},"Number of patients experiencing a unfavorable neurological outcome at 3 months, defined as changes in thinking, emotion, will and behavior.",{"measure":27,"description":32,"timeFrame":18},"Number of patients experiencing a unfavorable neurological outcome at 6 months, defined as changes in thinking, emotion, will and behavior.",{"measure":27,"description":34,"timeFrame":21},"Number of patients experiencing a unfavorable neurological outcome at 12 months, defined as changes in thinking, emotion, will and behavior.",{"measure":27,"description":36,"timeFrame":24},"Number of patients experiencing a unfavorable neurological outcome at 24 months, defined as changes in thinking, emotion, will and behavior.",{"measure":38,"description":39,"timeFrame":12},"Major adverse cardiac or cerebrovascular events","Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at discharge.",{"measure":38,"description":41,"timeFrame":15},"Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 3 months.",{"measure":38,"description":43,"timeFrame":18},"Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 6 months.",{"measure":38,"description":45,"timeFrame":21},"Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 12 months.",{"measure":38,"description":47,"timeFrame":24},"Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 24 months.",null,{"allocation":48,"interventionModel":48,"interventionModelDescription":48,"primaryPurpose":48,"observationalModel":50,"timePerspective":51,"maskingInfo":48},"COHORT","PROSPECTIVE","All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry",[54,58],{"label":55,"type":48,"description":48,"interventionNames":56},"Surgical clipping",[57],"Procedure: Surgical clipping and endovascular coiling",{"label":59,"type":48,"description":48,"interventionNames":60},"Endovascular coiling",[57],[62],{"type":63,"name":64,"description":65,"armGroupLabels":66,"otherNames":48},"PROCEDURE","Surgical clipping and endovascular coiling","Surgical clipping: Apply aneurysm clip to clip the ruptured aneurysm. Endovascular coiling：Also called endovascular embolization, to block blood flow into an aneurysm.Preventing blood flow into an aneurysm helps to keep it from rupturing.",[59,55],[68,71,74,76,78,81,83,85,87,89,91],{"name":69,"affiliation":5,"role":70},"Fa Lin, MD","PRINCIPAL_INVESTIGATOR",{"name":72,"affiliation":5,"role":73},"Yuanli Zhao, MD","STUDY_CHAIR",{"name":75,"affiliation":5,"role":73},"Jizong Zhao, MD",{"name":77,"affiliation":5,"role":70},"Runting Li, MD",{"name":79,"affiliation":5,"role":80},"Xiaolin Chen, MD","STUDY_DIRECTOR",{"name":82,"affiliation":5,"role":70},"Yu Chen, MD",{"name":84,"affiliation":5,"role":70},"Junlin Lu, MD",{"name":86,"affiliation":5,"role":70},"Zhipeng Li, MD",{"name":88,"affiliation":5,"role":70},"Heze Han, MD",{"name":90,"affiliation":5,"role":70},"Debin Yan, MD",{"name":92,"affiliation":5,"role":73},"Shuo Wang, MD",[94,99],{"name":77,"role":95,"phone":96,"phoneExt":97,"email":98},"CONTACT","+8615753166690","+8613681107240","1011168227@qq.com",{"name":79,"role":95,"phone":100,"phoneExt":96,"email":101},"+8613810624845","xiaolinchen488@hotmail.com",[103,119],{"facility":5,"status":104,"city":105,"state":106,"zip":107,"country":108,"countryCode":109,"cosmosGeoPoint":110,"geoPoint":115,"contacts":116},"RECRUITING","Beijing","Beijing Municipality","100070","China","CN",{"type":111,"coordinates":112},"Point",[113,114],116.39723,39.9075,{"lat":114,"lon":113},[117,118],{"name":77,"role":95,"phone":96,"phoneExt":48,"email":98},{"name":79,"role":95,"phone":100,"phoneExt":48,"email":101},{"facility":120,"status":104,"city":121,"state":122,"zip":48,"country":108,"countryCode":109,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"The First People's Hospital of Neijiang","Neijiang","Sichuan",{"type":111,"coordinates":124},[125,126],105.06216,29.58354,{"lat":126,"lon":125},[129],{"name":130,"role":95,"phone":48,"phoneExt":48,"email":131},"Qian Wu, MD","wsq9385@163.com",{"type":70,"investigatorFullName":133,"investigatorTitle":134,"investigatorAffiliation":5,"oldNameTitle":48,"oldOrganization":48},"yuanli Zhao","Director of Department of Cerebrovascular Neurosurgery",[136],{"name":137,"class":6},"Peking University International Hospital","100422833","long-term-prognosis-of-emergency-aneurysmal-subarachnoid-hemorrhage-100422833",false,"NCT04785976","Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage","Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage: an MDT- Based Multicenter Cohort Study","LongTEAM","Inclusion Criteria:\n\n* All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry.\n\nExclusion Criteria:\n\n* None","ALL",{"count":148,"type":149},5000,"ESTIMATED","OBSERVATIONAL","Rupture of intracranial aneurysms can lead to extensive subarachnoid hemorrhage (SAH), a potentially fatal neurological emergency with mortality rates ranging from 8 to 67%. At present, surgical clipping (SC) and endovascular coiling (EC) are two main treatments for aneurysmal subarachnoid hemorrhage (aSAH), in recent years, the improvements in surgical equipment and techniques have already greatly improved the postoperative safety of patients. However, considering individual differences between patients, some still at risk due to possible complications during hospitalization or after discharge from the hospital, it will no doubt generate a large healthcare burden.\n\nThis prospective, observational clinical trial (LongTEAM) is to improve the diagnosis and treatment effect and efficiency in this field, reducing mortality, medical costs, and medical burden, while opening up new avenues for interdisciplinary clinical practice and scientific research exploration.",[153],"Aneurysmal Subarachnoid Hemorrhage","2023-11-30",{"date":156,"type":157},"2023-12-01","ACTUAL",{"date":159,"type":157},"2012-04-01",{"date":161,"type":149},"2032-04-01",{"name":5,"class":6},2]